News + Filings Transactions
|
Alkon Daniel L.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 12/16/2022 | Synaptogenix, Inc. | SNPX | Sale | Common Stock, par value $0.0001 per share | 19.7k | $1.17 | $23.1k | | 12/16/2022 |
| 11/15/2022 | Synaptogenix, Inc. | SNPX | Grant | Stock Option (Right to Buy) | 112k | $6.07 | $679.8k | | 11/15/2022 |
| 11/15/2022 | Synaptogenix, Inc. | SNPX | Grant | Stock Option (Right to Buy) | 75k | $6.07 | $455.2k | | 11/15/2022 |
| 07/13/2021 | Synaptogenix, Inc. | SNPX | Grant | Common Stock, par value $0.0001 per share | 43.8k | $0.00 | $0 | | 07/13/2021 |
| 07/13/2021 | Synaptogenix, Inc. | SNPX | Grant | Common Stock, par value $0.0001 per share | 80k | $0.00 | $0 | | 07/13/2021 |
| 06/14/2021 | Synaptogenix, Inc. | SNPX | Purchase | Common Stock, par value $0.0001 per share | 10k | $8.26 | $82.6k | | 06/14/2021 |
| 12/01/2020 | Neurotrope, Inc. | NTRP | Disposition | Common Stock | 29.7k | $0.00 | $0 | | 12/01/2020 |
| 12/01/2020 | Neurotrope, Inc. | NTRP | Disposition | Stock Option (right to buy) | 5.5k | $56.00 | $306.3k | | 12/01/2020 |
| 12/01/2020 | Neurotrope, Inc. | NTRP | Disposition | Stock Option (right to buy) | 124.3k | $10.56 | $1.3M | | 12/01/2020 |
| 12/01/2020 | Neurotrope, Inc. | NTRP | Disposition | Stock Option (right to buy) | 167k | $19.62 | $3.3M | | 12/01/2020 |
| 12/01/2020 | Neurotrope, Inc. | NTRP | Disposition | Stock Option (right to buy) | 150k | $3.93 | $589.5k | | 12/01/2020 |
| 12/01/2020 | Neurotrope, Inc. | NTRP | Disposition | Stock Option (right to buy) | 40k | $0.97 | $38.9k | | 12/01/2020 |
| 11/24/2020 | Neurotrope, Inc. | NTRP | Grant | Stock Option (right to buy) | 40k | $0.97 | $38.9k | | 11/24/2020 |
| 01/22/2019 | Neurotrope, Inc. | NTRP | Grant | Stock Option (right to buy) | 150k | $3.93 | $589.5k | | 01/22/2019 |
| 04/11/2017 | Neurotrope, Inc. | NTRP | Grant | | 167k | $19.62 | $3.3M | | 04/11/2017 |
| 11/21/2016 | Neurotrope, Inc. | NTRP | Grant | Stock Option | 4M | $0.33 | $1.3M | | 11/21/2016 |
|